By Julie Rovner Healthcare proved important but apparently not pivotal in the 2018 ELECTIONS on Nov. 6 as voters gave Democrats control of the U.S. House, left Republicans in charge in the Senate and appeared to order an expansion of Medicaid in at least three states long-controlled by Republicans. In taking
BTG plc highlighted the presentation of the two-year results for the SENTRY Trial at the Vascular Interventional Advances (VIVA) conference in Las Vegas. The prospective, multicenter trial of the BTG Sentry, the world’s first bioconvertible IVC filter, found that in addition to providing protection against pulmonary embolism (PE) during the
By Drew Altman With a Democratic House, a Republican Senate and President Trump in the White House, get ready for two years of maneuvering but little progress on healthcare — unless you look beyond Washington. What to watch: No new health legislation of any significance will pass in this Congress.
The Centers for Medicare & Medicaid Services (CMS) released the final 2019 Physician Fee Schedule (PFS) and the Quality Payment Program (QPP) rule Nov. 1. According to CMS officials, the final rule modernizes Medicare payment policies to promote access to virtual care, saving Medicare beneficiaries time and money while improving
The Centers for Medicare and Medicaid Services has proven that “final rules” are not always final. In response to complaints from physicians, CMS has delayed major changes to E/M codes until 2021. While CMS moved ahead with parts of its plan to consolidate codes for Medicare patient visits, it made
The Centers for Medicare & Medicaid Services (CMS) approved a waiver to implement work requirements in Wisconsin’s Medicaid program Oct. 31, making it the fourth state to enact such an approach. Under the waiver, beneficiaries in the state’s BadgerCare program would have to engage in 80 hours a month of “community
By: Dan Best SEE RELATED ARTICLE: http://www.veintherapynews.com/wp-admin/post.php?post=1557&action=edit Last week, as part of fulfilling President Trump’s promise to lower drug prices and cut down on foreign governments’ freeriding, HHS put forth a new way of paying for physician-administered drugs within Medicare, the International Price Index (IPI) Model. The model aims to: